S18-216 Predicting anthracycline treatment response in cancer patients Researchers at Stanford University's Curtis Laboratory have used gene expression to categorize the sensitivity and resistance of anthracycline chemotherapy in breast cancer patients with utmost precision. Gerald Crabtree Christina Curtis Jose Seoane Fernandez Jacob Kirkland